Antithrombotic activities of sulforaphane via inhibiting platelet aggregation and FIIa/FXa

Antiplatelet activity of L-sulforaphane by regulation of platelet activation factors, glycoprotein IIb/IIIa and thromboxane A2

(2013) Chung-Hun Oh et al.   BLOOD COAGULATION & FIBRINOLYSIS

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

(2013) Edward C. Jauch et al.   STROKE

Antithrombotic and profibrinolytic activities of eckol and dieckol

(2012) Tae Hoon Kim et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

A novel antithrombotic effect of sulforaphane via activation of platelet adenylate cyclase: ex vivo and in vivo studies

(2012) Thanasekaran Jayakumar et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Old Versus New Oral Anticoagulants: Focus on Pharmacology

(2011) Jawed Fareed et al.   Annual Review of Pharmacology and Toxicology

PKC inhibitors RO 31-8220 and Gö 6983 enhance epinephrine-induced platelet aggregation in catecholamine hypo-responsive platelets by enhancing Akt phosphorylation

(2011) Sun-Young Kim et al.   BMB Reports

Antithrombotic and profibrinolytic activities of phloroglucinol

(2011) Jong-Sup Bae   FOOD AND CHEMICAL TOXICOLOGY

Old and new anticoagulants

(2011) U. Harbrecht   Hamostaseologie

Endothelial Atheroprotective and Anti-inflammatory Mechanisms

(2010) BRADFORD C. BERK et al.   Annals of the New York Academy of Sciences

Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway

(2008) Wen Lin et al.   BIOCHEMICAL PHARMACOLOGY